The Most Trusted Name in Securities Class Action Law Firms
Over a billion dollars recovered for investors and counting
uniQure N.V.
According to the lawsuit, defendants misrepresented and/or failed to disclose that: the design of uniQure’s Pivotal Study (a study of uniQure’s leading drug candidate in
BlackRock TCP Capital Corp.
According to the lawsuit, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about BlackRock TCP’s business, operations,
Kyndryl Holdings, Inc.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Kyndryl’s financial statements issued during the Class Period were materially
KDDI Corporation
On February 6, 2026, KDDI posted an announcement on its website entitled “Notice Regarding Expectation that Disclosure of Earnings Report for the Third Quarter of
Inovio Pharmaceuticals, Inc.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: manufacturing for Inovio’s CELLECTRA device was deficient; accordingly, Inovio was
Masonite International Corporation
According to the lawsuit, throughout the Class Period, defendants made material omissions and misrepresentations concerning Owens Corning’s offers to purchase all of Masonite’s outstanding common stock
Hub Group, Inc.
On February 5, 2026, after market hours, Hub Group filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing preliminary financial
Paysafe Limited
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Paysafe’s ecommerce business had significant exposure to a single high
PomDoctor Ltd.
According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: PomDoctor was the subject of
GSI Technology Inc.
On February 3, 2026, a post was issued on Stockwits in which it stated that “GSI is almost certainly hiding that their chip did not
Ultragenyx Pharmaceutical Inc.
According to the lawsuit, defendants provided investors with material information concerning Ultragenyx’s expected results for its Phase III Orbit and Cosmic Studies, which tested setrusumab
Mereo BioPharma Group plc
According to the lawsuit, defendants provided investors with material information concerning their expected results for the Phase 3 Orbit and COSMIC studies for setrusumab in
Picard Medical, Inc.
According to the complaint, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Picard’s business, operations, and the true
Plug Power Inc.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: defendants had materially overstated the likelihood that funds attributed to
uniQure N.V.
According to the lawsuit, defendants misrepresented and/or failed to disclose that: the design of uniQure’s Pivotal Study (a study of uniQure’s leading drug candidate in
BlackRock TCP Capital Corp.
According to the lawsuit, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about BlackRock TCP’s business, operations,
Kyndryl Holdings, Inc.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Kyndryl’s financial statements issued during the Class Period were materially
KDDI Corporation
On February 6, 2026, KDDI posted an announcement on its website entitled “Notice Regarding Expectation that Disclosure of Earnings Report for the Third Quarter of
Inovio Pharmaceuticals, Inc.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: manufacturing for Inovio’s CELLECTRA device was deficient; accordingly, Inovio was
Masonite International Corporation
According to the lawsuit, throughout the Class Period, defendants made material omissions and misrepresentations concerning Owens Corning’s offers to purchase all of Masonite’s outstanding common stock
Hub Group, Inc.
On February 5, 2026, after market hours, Hub Group filed a Current Report with the Securities and Exchange Commission on Form 8-K announcing preliminary financial
Paysafe Limited
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: Paysafe’s ecommerce business had significant exposure to a single high
PomDoctor Ltd.
According to the lawsuit, throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: PomDoctor was the subject of
GSI Technology Inc.
On February 3, 2026, a post was issued on Stockwits in which it stated that “GSI is almost certainly hiding that their chip did not
Ultragenyx Pharmaceutical Inc.
According to the lawsuit, defendants provided investors with material information concerning Ultragenyx’s expected results for its Phase III Orbit and Cosmic Studies, which tested setrusumab
Mereo BioPharma Group plc
According to the lawsuit, defendants provided investors with material information concerning their expected results for the Phase 3 Orbit and COSMIC studies for setrusumab in
Picard Medical, Inc.
According to the complaint, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about Picard’s business, operations, and the true
Plug Power Inc.
According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: defendants had materially overstated the likelihood that funds attributed to
Our Mission
The Rosen Law Firm, P.A. is dedicated to recovering damages for shareholders victimized by corporate fraud and other misconduct. Our attorneys have a wealth of knowledge and experience handling complex financial litigation and winning significant victories and settlements for our clients. By focusing exclusively on securities class actions and derivative litigation, we have risen to the forefront of plaintiffs’ firms and have recovered damages totaling hundreds of millions of dollars for our clients. Our mission is to protect shareholders rights.
Our Award Winning Attorneys
Featured News
Plaintiffs Reach Further Settlement in Just Energy Securities Class Action
TORONTO, Aug. 23, 2025 /CNW/ – The Court-appointed representatives of a class of former shareholders of Just Energy Group Inc. (“Just Energy”) have reached a settlement of the class action commenced following Just Energy’s August 2019 restatement of its financial statements. Just Energy’s insurers have agreed to pay US$25,000,000 to settle the claims made against Just Energy
Rosen Law Firm Ranked No. 2 in Number of 2021 Securities Class Action Settlements by ISS.
The firm was RANKED NO. 2 IN THE NUMBER OF SECURITIES CLASS ACTON SETTLEMENTS FOR 2021. Our firm has been ranked in the Top 4 each year since 2013. As a Top 10 law firm, we rank among the top plaintiffs’ firms for total settlement funds recovered in 2021 as
Latest News
The Rosen Law Firm P.A. Announces Proposed Settlement on Behalf of Purchasers of DiDi Global Inc. American Depositary Shares
NEW YORK, Feb. 9, 2026 /PRNewswire/ — The Rosen Law Firm P.A. announces that the United States District Court for the Southern District of New York has approved the following announcement of a proposed settlement that would benefit purchasers of DiDi Global Inc. American Depositary Shares (OTCMKTS: DIDIY) (formerlyNYSE: DIDI): UNITED STATES DISTRICT
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Securities of Arrival SA and/or CIIG Merger Corp. – ARVLF
BROOKLYN, N.Y., Dec. 08, 2025 (GLOBE NEWSWIRE) — The Rosen Law Firm, P.A. announces that the United States District Court for the Eastern District of New York has approved the following announcement of a proposed class action settlement that would benefit purchasers of securities of Arrival SA and/or CIIG Merger
FAQ
Class actions are lawsuits where one or more investors serve as the representative plaintiffs on behalf of a large group of investors that each purchased the same securities and suffered losses as a result of the same false statements or misconduct. Class actions allow a court to decide the claims of many investors in a single lawsuit. This promotes efficiency, economy, and extends justice to investors whose claims are not large enough to merit an individual lawsuit.
This is the time period during which investors purchased securities in the company that is the subject of the class action. Typically, the false statements or fraud begin on the first day of the class period and the full truth about the false statements or fraud is revealed on the last day of the class period.
A lead plaintiff is an investor that wishes to serve as a representative plaintiff in the class action on behalf of all the other investors that purchased securities during the Class Period.
The Lead Plaintiff’s role is to oversee the litigation with the assistance and advice of the class’s attorneys. Both the Lead Plaintiff and the class’s attorneys must direct the litigation for the benefit of the class foremost. Ultimately, it is the job of the Lead Plaintiff to decide what is a fair settlement amount for the Class and to approve any settlement offer.
Lead Counsel are the Class’s attorneys. The Lead Plaintiff selects the Lead Counsel. Lead Counsel should have extensive experience prosecuting securities class actions if they are to effectively represent investors in a securities class action.
If the amount of your losses in the investment are significant to you, being a lead plaintiff allows you to be involved in the case and oversee important decisions in the litigation, particularly the amount of any settlement for investors.
Class action lawsuits often are filed when it would be impractical or prohibitively expensive for each person who was harmed to file an individual lawsuit, and they enable small shareholders or consumers to seek recovery from large corporations possessing much greater legal and financial resources. Generally, securities class actions are filed in the Federal District Courts and allege that the defendant(s) violated the Securities Act of 1933 and/or the anti-fraud provisions of the Securities Exchange Act of 1934. The typical class action takes at least 2-3 years to litigate, although the actual time it takes to resolve a case varies, depending on the complexity of the case, the issues involved, and other factors.
You can complete the online certification form on our website or at your request, we will email you a form to complete and you can send it back to us.
You do not pay any legal fees, costs or expenses. The Court will award the Lead Counsel any legal fees, costs or expenses from the money they recover for the class. If Lead Counsel doesn’t recover any money for the class, Lead Counsel doesn’t get paid any legal fees, costs or expenses.
Our Offices
New York
275 Madison Avenue,
40th Floor
New York, NY 10016
T: 212.686.1060
F: 212.202.3827
Los Angeles
355 South Grand Avenue, Suite 2450
Los Angeles, CA 90071
T: 213.785.2610
F: 213.226.4684
Philadelphia Metro
101 Greenwood Avenue,
Suite 440
Jenkintown, PA 19046
T: 215.600.2817
F: 212.202.3827
New Jersey
One Gateway Center,
Suite 2600
Newark, NJ 07102
T: 973.313.1887
F: 973.833.0399
Get a Free Consultation
The Rosen Law Firm is dedicated exclusively to recovering investment losses for investors in companies that have misrepresented material aspects of their business or whose officers and directors have breached their fiduciary duties to shareholders.